Categories
Change Password!
Reset Password!
For streamlining the evaluation of responses to acute drugs and the identification of triptan non-responders in clinical settings, the EHF Consensus Panel has introduced practical, experience-based definitions to simplify the assessment of treatment outcomes for patients with migraine.
In a significant development in the field of migraine treatment, the European Headache Federation (EHF) consensus has been reached on defining the effectiveness of triptan medications in managing acute migraine attacks. Triptans, well-established migraine-specific treatments, have long been used, but there has been a need for clear criteria to determine when these treatments are successful or unsuccessful.
Defining Effective Migraine Treatment
The consensus panel, comprised of experts in the field, conducted an extensive process to establish these crucial definitions. As per the panel, effective management of a migraine attack is characterized by three key factors:
Furthermore, an acute migraine attack is deemed successfully treated when the patient's well-being is restored within a span of 2 hours and this alleviation of symptoms endures for a minimum of 24 hours.
Defining Triptan Response
In the realm of triptan response, the panel established the following definitions:
Implications for Clinical Practice and Research
These novel definitions hold significant promise for clinical practice and research in the field of migraine management. They provide a standardized framework for assessing the effectiveness of acute migraine treatments, helping healthcare professionals identify patients who do not respond to triptans and may require alternative treatments.
Additionally, these definitions will contribute to the standardization of research in the area of migraine acute care, potentially leading to the development of better treatments for this debilitating condition. This consensus represents a major step forward in enhancing the care and understanding of migraine patients and brings hope for improved treatment outcomes in the future.
The Journal of Headache and Pain
European Headache Federation (EHF) consensus on the definition of effective treatment of a migraine attack and of triptan failure
Simona Sacco et al.
Comments (0)